About Connor Rudny

This author has not yet filled in any details.
So far Connor Rudny has created 4 blog entries.

Webinar: Public Markets’ Impact on Manufacturing Advanced Therapies

2022-06-17T13:26:20-04:00Events|

Commercial viability for cell and gene therapy requires the right approach to manufacturing. This webinar, sponsored by Project Farma and Precision ADVANCE will address public market trends and their impact on the decision to manufacture cell and gene therapies internally or with an external supplier such as a CDMO. Our panel of experts will discuss their organizations’ pipeline, the advanced therapy investment landscape, and the regulatory, manufacturing, and commercial requirements for successfully bringing an advanced therapy to market.

(more…)

Publication: Value of a Cure for Sickle Cell Disease in Reducing Economic Disparities

2022-06-17T10:01:00-04:00Cell & Gene Therapy, Thought Leadership|

If a genetic therapy was created to cure sickle cell disease, how might this affect the productivity and earnings of an individual with the disease? How might this change also affect wider economic disparities? PRECISIONheor’s Marlon Graf (Senior Research Economist), Rifat Tuly (Research Scientist), and Jeff Sullivan (Senior Director) recently constructed a model to answer these impactful questions.

(more…)